U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...

Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

Merck & Co., Inc. (NYSE ... He also said that the company’s decision to invest in domestic manufacturing was driven by “what the current administration is doing and what President Trump ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

A new manufacturing plant in De Soto will be a Center of Excellence for the global company, along with expanded R&D ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Merck Animal Health Announces $895 Million ... and Gilead have recently announced additional investments to boost domestic production amid U.S. President Donald Trump's tariff policies.